Cystinosis
Research on cystinosis detailed by R. Tavares and co-authors
Published in Drug Week, October 16th, 2009
"The purpose of this study was to evaluate the efficacy of cysteamine eyedrops 0.1136% (new formulation, now stable at room temperature without the need for refrigeration for up to 2 months) for the treatment of cystine crystals in the cornea using slit lamp biomicroscopy and confocal microscopy. A 20-year-old woman with infantile cystinosis, with a history of kidney transplantation at age 10, was studied," researchers in Coimbra, Portugal report.
"She applied cysteamine eyedrops (0.1136%) 10 times a day (a new formulation, now stable at room temperature without the need for refrigeration for up to 2 months, was prepared for compassionate use). The density of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-10-16)
More Articles from Drug Week
- American Association for Cancer Research
Lack of social interaction affects health outcomes of breast cancer - American Friends of Tel Aviv University
Scary music is scarier with your eyes shut - American Gastroenterological Association
Antidepressant and placebo are equally effective in child pain relief - BioMed Central
Personality traits influencing weight loss - Boston University Medical Center
Researchers believe hormone therapy should not be stopped prior to mammograms - Elsevier Health Sciences
Paradoxically, food insecurity may be underlying contributor to overweight - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
